Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis

15 December 2007

journal article
research article
Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy

Vol. 64 (24), 2561-2568
https://doi.org/10.2146/ajhp060584

Abstract

Purpose. The comparative cost-effectiveness of voriconazole and amphotericin B in the treatment of invasive pulmonary aspergillosis (IPA) was examined.

Keywords

VORICONAZOLE AND AMPHOTERICIN
DECISION TREE
HEALTH CARE COSTS
HALO SIGN
TREATMENT OUTCOMES
COMPARATIVE COST EFFECTIVENESS

Cited by 13 articles